A Randomized Phase II Clinical Trial of Tailored CPT-11 + S-1 vs S-1 in Patients with Advanced or Recurrent Gastric Carcinoma as the First Line Chemotherapy
Phase 2
- Conditions
- Advanced or recurrent gastric cancer
- Registration Number
- JPRN-C000000099
- Lead Sponsor
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of using S-1 2) Medical history of allergy or hypersensitivity reactions to any drug 3) Serious effusion of cancerous fluids such as pleural effusion and/or ascites 4) Serious infectious disease 5) Diarrhea 6) Ileus or colon dysfunction 7) Lung fibrosis 8) Intake of flucitosine 9) Synchronous or metachronous or other types of malignancies 10) Uncontrollable diabetes mellitus 11) Serious heart disease 12) Serious psychological disease 13) Pregnancy 14) Patients judged inappropriate for this study by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method